Canadian government ordered to release unpublished Tamiflu data in landmark rulingBMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3112 (Published 13 July 2018) Cite this as: BMJ 2018;362:k3112
- Gareth Iacobucci
- The BMJ
The Canadian government has been instructed to release unpublished clinical trial data relating to Tamiflu, Relenza, and three human papillomavirus vaccines immediately, in a landmark ruling hailed as a “major victory” for transparency.
The case was brought by Peter Doshi, assistant professor at the University of Maryland and associate editor of The BMJ, after Health Canada refused his request to obtain unpublished information relating to Tamiflu, Relenza, Gardasil, Gardasil 9, and Cervarix because he would not sign a confidentiality agreement that would have prevented him from disseminating or publishing anything on it.
A federal court judge said it was “unreasonable” for Health Canada to impose a confidentiality requirement as a condition for the disclosure …